Literature DB >> 8746772

Phosphorothioate oligodeoxynucleotides: antisense or anti-protein?

A M Krieg, C A Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8746772     DOI： 10.1089/ard.1995.5.241

Source DB:  PubMed          Journal:  Antisense Res Dev        ISSN： 1050-5261


× No keyword cloud information.
  28 in total

1.  Molecular correlates of the calcium-independent, depolarization-activated K+ currents in rat atrial myocytes.

Authors:  E Bou-Abboud; J M Nerbonne
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

2.  Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.

Authors:  F Shi; A Nomden; V Oberle; J B Engberts; D Hoekstra
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

Review 3.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

4.  Fluorescence cross-correlation spectroscopy reveals mechanistic insights into the effect of 2'-O-methyl modified siRNAs in living cells.

Authors:  Thomas Ohrt; Wolfgang Staroske; Jörg Mütze; Karin Crell; Markus Landthaler; Petra Schwille
Journal:  Biophys J       Date:  2011-06-22       Impact factor: 4.033

5.  Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo.

Authors:  B P Monia; H Sasmor; J F Johnston; S M Freier; E A Lesnik; M Muller; T Geiger; K H Altmann; H Moser; D Fabbro
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

6.  RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates.

Authors:  O Heidenreich; S Gryaznov; M Nerenberg
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

7.  Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides.

Authors:  G Lambert; E Fattal; H Pinto-Alphandary; A Gulik; P Couvreur
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

Review 8.  Canonical and non-canonical barriers facing antimiR cancer therapeutics.

Authors:  Christopher J Cheng; W Mark Saltzman; Frank J Slack
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 9.  Biological barriers to therapy with antisense and siRNA oligonucleotides.

Authors:  R Juliano; J Bauman; H Kang; X Ming
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

Review 10.  The use of antisense oligonucleotides in Xenopus oocytes.

Authors:  Alissa M Hulstrand; Patricia N Schneider; Douglas W Houston
Journal:  Methods       Date:  2010-01-05       Impact factor: 3.608
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.